These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 7664822

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pre-clinical studies of pramipexole: clinical relevance.
    Hubble JP.
    Eur J Neurol; 2000 May; 7 Suppl 1():15-20. PubMed ID: 11054154
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA, Chu A, Sibley DR.
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.
    Piercey MF.
    Clin Neuropharmacol; 1998 May; 21(3):141-51. PubMed ID: 9617505
    [Abstract] [Full Text] [Related]

  • 28. Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist.
    Camacho-Ochoa M, Walker EL, Evans DL, Piercey MF.
    Neurosci Lett; 1995 Aug 18; 196(1-2):97-100. PubMed ID: 7501268
    [Abstract] [Full Text] [Related]

  • 29. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN, Greedy B, Husbands SM, Grundt P, Newman AH, Woods JH.
    Psychopharmacology (Berl); 2009 Apr 18; 203(2):317-27. PubMed ID: 18807248
    [Abstract] [Full Text] [Related]

  • 30. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep 18; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 31. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U, Tränkle C, Mohr K, Gmeiner P.
    Pharmazie; 1999 Apr 18; 54(4):294-7. PubMed ID: 10234741
    [Abstract] [Full Text] [Related]

  • 32. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF, Bruhwyler J, Damas J, Rogister F, Masereel B, Geczy J, Delarge J.
    Eur J Pharmacol; 1995 Feb 06; 273(3):R1-3. PubMed ID: 7737323
    [Abstract] [Full Text] [Related]

  • 33. Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides.
    Malmberg A, Mohell N.
    J Pharmacol Exp Ther; 1995 Aug 06; 274(2):790-7. PubMed ID: 7636742
    [Abstract] [Full Text] [Related]

  • 34. Coupling of D2 and D3 dopamine receptors to G-proteins.
    Castro SW, Strange PG.
    FEBS Lett; 1993 Jan 11; 315(3):223-6. PubMed ID: 8422910
    [Abstract] [Full Text] [Related]

  • 35. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
    Coldwell MC, Boyfield I, Brown AM, Stemp G, Middlemiss DN.
    Br J Pharmacol; 1999 Jul 11; 127(5):1135-44. PubMed ID: 10455259
    [Abstract] [Full Text] [Related]

  • 36. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
    Perachon S, Schwartz JC, Sokoloff P.
    Eur J Pharmacol; 1999 Feb 05; 366(2-3):293-300. PubMed ID: 10082211
    [Abstract] [Full Text] [Related]

  • 37. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM, D'Souza UM, Strange PG.
    J Neurochem; 1995 Feb 05; 64(2):940-3. PubMed ID: 7830089
    [Abstract] [Full Text] [Related]

  • 38. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH.
    J Pharmacol Exp Ther; 2005 Jul 05; 314(1):310-9. PubMed ID: 15833897
    [Abstract] [Full Text] [Related]

  • 39. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms.
    Ramirez AD, Wong SK, Menniti FS.
    Eur J Pharmacol; 2003 Aug 15; 475(1-3):29-35. PubMed ID: 12954356
    [Abstract] [Full Text] [Related]

  • 40. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P, Scorza C, Monti JM, Jantos H, Reyes-Parada M, Silveira R, Ponzoni A.
    Eur Neuropsychopharmacol; 1998 May 15; 8(2):113-20. PubMed ID: 9619689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.